The following material has been sourced from the Australian Institute of Health and Welfare
Testicular cancer incorporates ICD-10 cancer code C62 (Malignant neoplasm of testis).
Estimated number of new cases of testicular cancer diagnosed in 2022
964 males
Estimated % of all new male cases of cancer diagnosed in 2022
1.1%
Estimated number of deaths from testicular cancer in 2022
31 males
Estimated % of male deaths from cancer in 2022
0.11%
Chance of surviving at least 5 years (2014–2018)
97%
People living with testicular cancer at the end of 2017 (diagnosed in the 5 year period 2013 to 2017)
4,058
New cases
In 2018, there were 898 new cases of testicular cancer diagnosed in Australia. In 2022, it is estimated that 964 new cases of testicular cancer will be diagnosed in Australia. In 2022, it is estimated that a male has a 1 in 181 (or 0.55%) risk of being diagnosed with testicular cancer by the age of 85.
Figure 1. Estimated cancer incidence in Australia among males, 2022
Notes
- Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
- More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)
In 2018, the age-standardised incidence rate was 7.4 cases per 100,000 males. In 2022, it is estimated that the age-standardised incidence rate will be 7.8 cases per 100,000 males. The incidence rate for testicular cancer is expected to be highest for those aged 30–34 years, and then decrease.
Figure 2. Age-standardised incidence rates for testicular cancer, 1982 to 2018
Notes
- Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
- More information about incidence rates for testicular cancer over time, by age, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)
The number of new cases of testicular cancer diagnosed increased from 321 in 1982 to 898 in 2018. Over the same period, the age-standardised incidence rate increased from 4.2 cases per 100,000 males in 1982 to 7.4 cases per 100,000 in 2018.
Deaths
In 2020, there were 19 deaths from testicular cancer in Australia. In 2022, it is estimated that there will be 31 deaths. In 2022, it is estimated that a male had a 1 in 5,335 (or 0.02%) risk of dying from testicular cancer by the age of 85.
Figure 3. Estimated cancer mortality in Australia among males, 2022
Notes
- Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
- More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)
In 2020, the age-standardised mortality rate was 0.2 deaths per 100,000 males. In 2022, it is estimated that the age-standardised mortality rate will be 0.2 deaths per 100,000 males. The mortality rate for testicular cancer is expected to vary across age groups.
Figure 4. Age-standardised mortality rates for testicular cancer, 1982 to 2020
Notes
- Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
- More information about mortality rates for testicular cancer over time, by age, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)
The number of deaths from testicular cancer decreased from 34 in 1982 to 19 in 2020. Over the same period, the age-standardised mortality rate remained similar from 0.5 deaths per 100,000 males in 1982 to 0.2 deaths per 100,000 males in 2020.
Survival
In 2014–2018, individuals diagnosed with testicular cancer had a 97% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1989–1993 and 2014–2018, five-year relative survival for testicular cancer improved from 95% to 97%.
Figure 5. 5-year relative survival for testicular cancer, 1989–1993 to 2014–2018, by sex
Notes
- Data sourced from AIHW Cancer Data in Australia 2022 web report and supplementary data tables
- More information about 5-year relative survival rates for testicular cancer over time, by age, sex, Indigenous status, remoteness, and socioeconomic status (SES) can be found on the NCCI website in the ‘Relative survival rate’ section (https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival-diagnosis)
Prevalence
At the end of 2017, there were 882 people living who had been diagnosed with testicular cancer that year, 4,058 people living who had been diagnosed with testicular cancer in the previous 5 years (from 2013 to 2017) and 18,676 people living who had been diagnosed with testicular cancer in the previous 36 years (from 1982 to 2017).
For more information, see Testicular cancer on the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.
